Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-16-588250
Filing Date
2016-05-12
Accepted
2016-05-12 09:43:14
Documents
78
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d90164d10q.htm 10-Q 366201
2 EX-31.1 d90164dex311.htm EX-31.1 8430
3 EX-31.2 d90164dex312.htm EX-31.2 8533
4 EX-32.1 d90164dex321.htm EX-32.1 4113
  Complete submission text file 0001193125-16-588250.txt   3724993

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT reph-20160331.xml EX-101.INS 565790
6 XBRL TAXONOMY EXTENSION SCHEMA reph-20160331.xsd EX-101.SCH 52860
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE reph-20160331_cal.xml EX-101.CAL 76372
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE reph-20160331_def.xml EX-101.DEF 213151
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE reph-20160331_lab.xml EX-101.LAB 422745
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE reph-20160331_pre.xml EX-101.PRE 343409
Mailing Address 490 LAPP ROAD MALVERN PA 19355
Business Address 490 LAPP ROAD MALVERN PA 19355 (484) 395-2400
Recro Pharma, Inc. (Filer) CIK: 0001588972 (see all company filings)

EIN.: 261523233 | State of Incorp.: PA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36329 | Film No.: 161641960
SIC: 2834 Pharmaceutical Preparations